Cargando…

Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial

BACKGROUND: Postoperative sore throat is a frequent adverse event after double-lumen endobronchial tube (DLT) intubation. The aim of this study was to investigate whether esketamine gargle has a preventive effect on the incidence of postoperative sore throat in patients undergoing DLT intubation. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jianfen, Liu, Jun, Qiu, Zhuolin, Sun, Guoliang, Xiang, Ping, Hei, Ziqing, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591602/
https://www.ncbi.nlm.nih.gov/pubmed/37876501
http://dx.doi.org/10.2147/DDDT.S430077
_version_ 1785124257377812480
author Liang, Jianfen
Liu, Jun
Qiu, Zhuolin
Sun, Guoliang
Xiang, Ping
Hei, Ziqing
Li, Xiang
author_facet Liang, Jianfen
Liu, Jun
Qiu, Zhuolin
Sun, Guoliang
Xiang, Ping
Hei, Ziqing
Li, Xiang
author_sort Liang, Jianfen
collection PubMed
description BACKGROUND: Postoperative sore throat is a frequent adverse event after double-lumen endobronchial tube (DLT) intubation. The aim of this study was to investigate whether esketamine gargle has a preventive effect on the incidence of postoperative sore throat in patients undergoing DLT intubation. METHODS: This trial included 140 patients undergoing elective thoracic surgery at the third affiliated hospital of Sun Yat-Sen University. Patients were randomly allocated into the following two groups of 70 patients each: the control group, gargling with saline of 30 mL, and the esketamine group, gargling with an esketamine solution of 30 mL (2 mL/50 mg esketamine in 28 mL saline), 5 min prior to anaesthesia induction. The primary outcome was the incidence of sore throat 24 h after surgery. The main secondary outcomes included the incidence of sore throat and hoarseness at 1 h and 48 h after surgery, as well as the intraoperative haemodynamic responses. RESULTS: The incidence of sore throat was significantly higher in the control group (47.1%, 33/70 patients) compared with the esketamine group (12.9%, 9/70 patients) at 24 h after surgery (RD, 0.41; 95% confidence interval, 0.26–0.57; p < 0.001). Furthermore, the incidence of sore throat at 1 h (p = 0.027), 24 h (p = 0.019), and seventh day (p = 0.031) as well as hoarseness at 1 h (p = 0.027), 24 h (p = 0.019), and 48 h (p = 0.031) after surgery were reduced in the esketamine group. Significant differences were seen in the peak levels of systolic blood pressure, mean arterial blood pressure, and heart rate between the groups during the intubation (p < 0.05). Besides, no patient developed an adverse reaction to esketamine. CONCLUSION: Preoperative gargling of esketamine can provide an effect against sore throat after DLT intubation without adverse side effects and effectively inhibit sharp elevations in heart rate and blood pressure during double-lumen intubation procedures.
format Online
Article
Text
id pubmed-10591602
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105916022023-10-24 Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial Liang, Jianfen Liu, Jun Qiu, Zhuolin Sun, Guoliang Xiang, Ping Hei, Ziqing Li, Xiang Drug Des Devel Ther Original Research BACKGROUND: Postoperative sore throat is a frequent adverse event after double-lumen endobronchial tube (DLT) intubation. The aim of this study was to investigate whether esketamine gargle has a preventive effect on the incidence of postoperative sore throat in patients undergoing DLT intubation. METHODS: This trial included 140 patients undergoing elective thoracic surgery at the third affiliated hospital of Sun Yat-Sen University. Patients were randomly allocated into the following two groups of 70 patients each: the control group, gargling with saline of 30 mL, and the esketamine group, gargling with an esketamine solution of 30 mL (2 mL/50 mg esketamine in 28 mL saline), 5 min prior to anaesthesia induction. The primary outcome was the incidence of sore throat 24 h after surgery. The main secondary outcomes included the incidence of sore throat and hoarseness at 1 h and 48 h after surgery, as well as the intraoperative haemodynamic responses. RESULTS: The incidence of sore throat was significantly higher in the control group (47.1%, 33/70 patients) compared with the esketamine group (12.9%, 9/70 patients) at 24 h after surgery (RD, 0.41; 95% confidence interval, 0.26–0.57; p < 0.001). Furthermore, the incidence of sore throat at 1 h (p = 0.027), 24 h (p = 0.019), and seventh day (p = 0.031) as well as hoarseness at 1 h (p = 0.027), 24 h (p = 0.019), and 48 h (p = 0.031) after surgery were reduced in the esketamine group. Significant differences were seen in the peak levels of systolic blood pressure, mean arterial blood pressure, and heart rate between the groups during the intubation (p < 0.05). Besides, no patient developed an adverse reaction to esketamine. CONCLUSION: Preoperative gargling of esketamine can provide an effect against sore throat after DLT intubation without adverse side effects and effectively inhibit sharp elevations in heart rate and blood pressure during double-lumen intubation procedures. Dove 2023-10-19 /pmc/articles/PMC10591602/ /pubmed/37876501 http://dx.doi.org/10.2147/DDDT.S430077 Text en © 2023 Liang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liang, Jianfen
Liu, Jun
Qiu, Zhuolin
Sun, Guoliang
Xiang, Ping
Hei, Ziqing
Li, Xiang
Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial
title Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial
title_full Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial
title_fullStr Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial
title_full_unstemmed Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial
title_short Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial
title_sort effect of esketamine gargle on postoperative sore throat in patients undergoing double-lumen endobronchial intubation: a randomised controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591602/
https://www.ncbi.nlm.nih.gov/pubmed/37876501
http://dx.doi.org/10.2147/DDDT.S430077
work_keys_str_mv AT liangjianfen effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial
AT liujun effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial
AT qiuzhuolin effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial
AT sunguoliang effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial
AT xiangping effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial
AT heiziqing effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial
AT lixiang effectofesketaminegargleonpostoperativesorethroatinpatientsundergoingdoublelumenendobronchialintubationarandomisedcontrolledtrial